| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 47,495 | 55,993 | 46,043 | | Cost of Revenue | 12,906 | 18,866 | 15,227 | | | Gross Profit | 34,589 | 37,127 | 30,816 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 30,777 | 29,898 | 22,081 | | Non Recurring | 7,055 |
-
| 1,366 | | Others | 3,023 | 222 | 1,602 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (6,266) | 7,007 | 5,767 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (6,266) | 7,007 | 5,767 | | Interest Expense | 3,600 | 3,790 | 4,007 | | Income Before Tax | (9,866) | 3,217 | 1,760 | | Income Tax Expense | (3,202) | (892) | (823) | | Minority Interest | (360) | (146) |
-
| | | | Net Income From Continuing Ops | (7,024) | 3,963 | 2,583 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,024) | 3,963 | 2,583 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,024) | $3,963 | $2,583 |
|
0.83% Nasdaq 
Income Statement
